Inmune Bio Inc (INMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 0 | 0 | 0 | 0 | 50 |
| Gross Profit | N/A | N/A | N/A | N/A | 50 |
| Operating Expenses | 5,812 | 5,474 | 7,433 | 24,571 | 9,955 |
| Operating Income | -5,812 | -5,474 | -7,433 | -24,571 | -9,905 |
| Other Income | 405 | 210 | 961 | 113 | 166 |
| Pre-tax Income | -5,407 | -5,264 | -6,472 | -24,458 | -9,739 |
| Net Income Continuous | -5,407 | -5,264 | -6,472 | -24,458 | -9,739 |
| Net Income | $-5,407 | $-5,264 | $-6,472 | $-24,458 | $-9,739 |
| EPS Basic Total Ops | -0.20 | -0.14 | -0.24 | -1.05 | -0.43 |
| EPS Basic Continuous Ops | -0.20 | -0.13 | -0.24 | -1.05 | -0.43 |
| EPS Diluted Total Ops | -0.20 | -0.14 | -0.24 | -1.05 | -0.43 |
| EPS Diluted Continuous Ops | -0.20 | -0.13 | -0.24 | -1.05 | -0.43 |
| EPS Diluted Before Non-Recurring Items | -0.20 | -0.18 | -0.24 | -0.34 | -0.43 |
| EBITDA(a) | $-5,760 | $-5,418 | $-7,433 | $-24,571 | $-9,905 |